David Hallal - 11 Jun 2024 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Director
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
11 Jun 2024
Transactions value $
$0
Form type
4
Filing time
13 Jun 2024, 20:00:08 UTC
Previous filing
07 Jun 2024
Next filing
14 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITOS Stock Option (Right to Buy) Award $0 +24,200 $0.000000 24,200 11 Jun 2024 Common Stock 24,200 $16.32 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.